Conclusion
New funding as a result of the global pandemic influenza action plan to increase supply has spurred vaccine industry initiatives
in planning manufacturing capacity. Given uncertain factors and the potential surge capacity requirement involved in the avian
or pandemic influenza vaccine market, preparedness could come at a high cost. Although such a pre-emptive measure is the right
step forward, a key question the vaccine manufacturing community must ask is "What production and facility concepts should
be applied to provide a good business case?"
Aeby Thomas is a process engineer at NNE Pharmaplan, Søborg, Denmark, +45 4444 7777, aebt@nnepharmaplan.com
. At the same company, Niels Guldager is a specialist, business consulting services, and Klaus Hermansen is a senior specialist, business consulting services.
Suggested Reading
1. World Health Organization (WHO). Global pandemic influenza action to increase vaccine supply. Geneva, Switzerland: WHO
Epidemic and Pandemic Alert Response (EPR) Publications; 2006 [cited July 1, 2007]. Available from:
http://www.who.int/csr/resources/publications/influenza/CDS_EPR_GIP_2006_1.pdf.
2. World Health Organization (WHO). Working paper 1: Increasing production capacity for pandemic influenza vaccines. Draft
doc., v. 4. Geneva, Switzerland: WHO Initiative for Vaccine Research (IVR); n.d. [cited July 1, 2007]. Available from:
http://www.who.int/vaccine_research/diseases/influenza/Working_Paper_1.pdf.
3. International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Influenza Vaccine Supply International
Task Force (IVS ITF). R&D for avian/pandemic influenza vaccines. Geneva, Switzerland: IFPMA; 2006 October 17 [cited July 1,
2007]. Available from:
http://www.ifpma.org/Influenza/content/pdfs/Table_Avian_Pandemic_Influenza_RnD_17Oct06.pdf
4. Rappouli R. Cell-culture based vaccine production: Technological options. The Bridge [serial online] 2006 Fall [cited
July 1, 2007];36(3). Available from:
http://www.nae.edu/nae/bridgecom.nsf/weblinks/MKEZ-6SZR4L?OpenDocument.
5. Galliher PM. Review of single-use technologies in biomanufacturing. Worcester Polytechnic Institute, Bioengineering Institute
Symposium: New Developments in Biomanufacturing. 2007 Feb 20; Worcester, MA; 2007 [Cited July 1, 2007]. Available from:
http://www.wpi.edu/Images/CMS/BEI/parrishgalliher.pdf.
|
